New study reveals hidden factors behind daily struggles in hemophilia
NCT ID NCT07523399
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 36 adults with severe hemophilia A to understand how joint health, pain, balance, and falls impact their quality of life. Researchers will measure joint damage, balance using a special platform, pain levels, and fall history. The goal is to find which factors matter most, so doctors can design better rehabilitation programs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify which factors (like joint health or balance) most affect quality of life, pointing toward better rehabilitation strategies for adults with hemophilia A.
- What could go wrong
- This is a small, observational study with only 36 participants, so findings may not apply to all people with hemophilia. It does not test a treatment, so no direct health benefits are expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 36 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults with hemophilia A
- Ages
-
18 to 65 years
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of severe hemophilia A * Age ≥18 years * A minimum single-joint score of 3 points for the knee or ankle according to the Hemophilia Joint Health Score (HJHS) Exclusion Criteria: * Use of walking aids (e.g., crutches) * Presence of neurological or psychiatric disorders, chronic inflammatory disease, -Regular use of medications that could affect balance, * History of major lower extremity surgery within the previous six months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemophilia A are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Van Yuzuncu Yil University
RECRUITINGVan, 65080, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a newer clotting factor keep its effectiveness in hemophilia a?
- Can a new injection tame hemophilia a bleeding?
- A Once-a-Week shot could transform hemophilia Care—Even for those with inhibitors
- Can a new clotting factor offer better bleed protection for severe hemophilia?
- Do newer hemophilia drugs protect joints better? study aims to find out
- Newborn screening study aims to catch rare diseases at birth